NCT00476918

Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema

Dosage Dependency of Intravitreal Triamcinolone Acetonide for Treatment of Diabetic Macular Edema

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Heidelberg University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Efficacy duration of triamcinolone acetonide (steroid) for treatment of diabetic macular edema. Furthermore, dosage dependency of triamcinolone acetonide comparing a high dosage versus a low dosage.

Detailed description

Patients with diabetic retinopathy suffer from visual acuity loss caused by diabetic macular edema. Intravitreal injected Triamcinolone Acetonide (steroid) reduces macular edema and increases visual acuity. The duration of its effect is however limited. Therefore, several injections are necessary. In this study a dosage dependency of triamcinolone acetonide (high dosage vs low dosage) is performed. The primary outcome parameters are the number of treatments and the efficacy of each injection.

Conditions

• Diabetic Retinopathy
• Diabetic Macular Edema

Interventions

Type	Name	Description
DRUG	Intravitreal injection (triamcinolone acetonide)

Timeline

• Start date: 2006-07-01
• Completion: 2007-12-01
• First posted: 2007-05-22
• Last updated: 2007-05-22

Locations

1 site across 1 country: Germany